Home › EMMVEE › Filing
🔔 Get instant alerts when EMMVEE files quarterly results on BSE Start free trial →

Analysts/Institutional Investor Meet/Con. Call Updates

Filed: 21 Oct 2026, 18:07 IST Exchange: NSE Category: Financial Results — Earnings Call Transcript
AI summary - Q2FY27 revenue grew 39% y-y to INR1,576 Cr; H1 revenue up 45% to INR3,132 Cr - Q2 EBITDA margin steady at ~35.3%; H1 EBITDA margin ~35%; PAT up 61% in Q2, 79% in H1 - Cell production utilization at 89%, module at 44%; 6 GW integrated expansion on track for Dec 2026 (module) and Mar 2027 (cell) - Order book at 10.4 GW with 1.5 GW new inflows in Q2; 70% DCR, 30% non-DCR - Finance cost down sharply to INR9.5 Cr in Q2 from INR55.2 Cr last year; net debt/equity 0.12x - Capex INR5,500 Cr includes INR4,600 Cr hard cost plus margin money and IDC - Management confident of maintaining margins despite pricing pressures via efficiency and product differentiation
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 EMMVEE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add EMMVEE to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Emmvee Photovoltaic Power Limited

Important. The summary above is generated automatically from Emmvee Photovoltaic Power Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.